Weight & Anthropometrics

Evidence Snapshot

Evidence relationships

Studies reviewed

Interventions evaluated

Strongest evidence area

Semaglutide

Top Evidence Areas

Rank	Intervention	Outcome	Effectiveness	Strength	Consistency	Studies
#1	Basal insulin	Body weight	Moderate Negative	Weak	Unclear	1
#2	Boscisucrophage	Body weight	Moderate Positive	Limited	Unclear	1
#3	Dapagliflozin	Body weight	Moderate Positive	Limited	Unclear	1
#4	Exercise therapy	Pregnancy weight gain	Neutral	Weak	Unclear	1
#5	GLP 1 receptor agonists	Body weight	Moderate Positive	Limited	Unclear	1
#6	Insulin Glargine Lixisenatide dosis	BMI	Moderate Positive	Limited	Unclear	1
#7	Insulin Glargine Lixisenatide dosis	Body weight	Moderate Positive	Limited	Unclear	1
#8	Liraglutide	Body weight	Moderate Positive	Limited	Unclear	1
#9	Low Carbohydrate diet	BMI	Moderate Positive	Limited	Unclear	1
#10	Low Carbohydrate diet	Body weight	Moderate Positive	Limited	Unclear	1

Rank #1

Body weight

Basal insulin

Effectiveness

Moderate Negative

Strength

Weak

Consistency

Unclear

Studies

Rank #2

Body weight

Boscisucrophage

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Rank #3

Body weight

Dapagliflozin

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Rank #4

Pregnancy weight gain

Exercise therapy

Effectiveness

Neutral

Strength

Weak

Consistency

Unclear

Studies

Rank #5

Body weight

GLP 1 receptor agonists

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Rank #6

BMI

Insulin Glargine Lixisenatide dosis

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Rank #7

Body weight

Insulin Glargine Lixisenatide dosis

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Rank #8

Body weight

Liraglutide

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Rank #9

BMI

Low Carbohydrate diet

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Rank #10

Body weight

Low Carbohydrate diet

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Practical Questions

Which interventions are most often studied for Weight & Anthropometrics?

outcome

Based on 6 evidence relationships across 7 studies

Outcomes:

BMIBody weight

Interventions:

Insulin Glargine Lixisenatide dosisLow Carbohydrate dietSemaglutide

Which interventions need more research for Weight & Anthropometrics?

evidence

Based on 3 evidence relationships across 4 studies

Outcomes:

Body weight

Interventions:

Basal insulinBoscisucrophageSemaglutide

How does Semaglutide compare with Dapagliflozin for Weight & Anthropometrics?

compare

Low Evidence

Within Weight & Anthropometrics, the table evidence for Semaglutide and Dapagliflozin is similar or too limited to clearly favor one. Interpret cautiously when study counts are low.

Semaglutide

Evidence:53.0

Effectiveness:80.0

Studies:2

Pairs:1

moderate

Dapagliflozin

Evidence:53.0

Effectiveness:80.0

Studies:1

Pairs:1

moderate

No clear winner based on current evidence

Limitations

Limited supporting studies for at least one itemConsistency scores not available for all compared itemsSome compared items based on single evidence pair

Comparison based on limited supporting studies for at least one item.

What interventions show the most consistent effects for Weight & Anthropometrics?

practical use

Based on 17 evidence relationships across 18 studies

Outcomes:

Body weightPregnancy weight gainBMI

Interventions:

Basal insulinBoscisucrophageDapagliflozinExercise therapyGLP 1 receptor agonists+9 more

Evidence Landscape

Evidence landscape

Each bubble represents an evidence relationship. Position shows effectiveness and strength; size reflects study volume.

Limited evidence

Promising

Reliable

High impact

Lower Evidence Strength→Higher Evidence Strength

Lower Effectiveness→Higher Effectiveness

Explore by Intervention

Intervention	Pairs	Research	Avg Strength
Semaglutide	2	2	53
Basal insulin	1	1	26
Boscisucrophage	1	1	41
Dapagliflozin	1	1	53
Exercise therapy	1	1	34
GLP 1 receptor agonists	1	1	47
Insulin Glargine Lixisenatide dosis	2	1	45
Liraglutide	1	1	53
Low Carbohydrate diet	2	1	45
Metformin	1	1	53
Pioglitazone	1	1	32
Telemonitoring	1	1	35
Telephone counseling	1	1	45
Tirzepatide	1	1	53

Latest Research

AI virtual trials match real trial results for GLP-1 vs insulin in type 2 diabetes

Published: 16 de mayo de 2026

int-basal-insulinint-glp-1-receptor-agonists

out-body-weight

Newer diabetes drugs show stronger weight and blood sugar benefits in prediabetes

Published: 16 de mayo de 2026

int-dapagliflozinint-liraglutide

out-bmiout-body-weight

Telephone-based lifestyle education reduces gestational diabetes risk by 60% in high-risk Iranian women

Published: 7 de mayo de 2026

int-telephone-counseling

out-bmi

Supported telemonitoring improved HbA1c and blood pressure in type 2 diabetes

Published: 6 de mayo de 2026

int-telemonitoring

out-body-weight

Switching from MDI to iGlarLixi kept HbA1c similar and lowered weight

Published: 6 de mayo de 2026

int-insulin-glargine-lixisenatide-dosis

out-bmiout-body-weight

Semaglutide cuts insulin needs in adults with type 1 diabetes and obesity

Published: 6 de mayo de 2026

int-semaglutide

out-body-weight

Prenatal exercise may lower gestational diabetes risk, but not pregnancy weight gain

Published: 6 de mayo de 2026

int-exercise-therapy

out-pregnancy-weight-gain

Boscia senegalensis extract (BSP), a natural SGLT1/2 inhibitor, may lower blood sugar and HbA1c in type 2 diabetes

Published: 4 de mayo de 2026

int-boscisucrophage

out-body-weight

Remote nutrition education with low-carb diet improves blood sugar and reduces medication use in type 2 diabetes

Published: 4 de mayo de 2026

int-low-carbohydrate-diet

out-bmiout-body-weight

Full Evidence Table

Showing 17 of 17 evidence pairs

Intervention	Outcome	Effectiveness	Strength	Consistency	Studies
Basal insulin	Body weight	Moderate Negative	Weak	Unclear	1
Boscisucrophage	Body weight	Moderate Positive	Limited	Unclear	1
Dapagliflozin	Body weight	Moderate Positive	Limited	Unclear	1
Exercise therapy	Pregnancy weight gain	Neutral	Weak	Unclear	1
GLP 1 receptor agonists	Body weight	Moderate Positive	Limited	Unclear	1
Insulin Glargine Lixisenatide dosis	BMI	Moderate Positive	Limited	Unclear	1
Insulin Glargine Lixisenatide dosis	Body weight	Moderate Positive	Limited	Unclear	1
Liraglutide	Body weight	Moderate Positive	Limited	Unclear	1
Low Carbohydrate diet	BMI	Moderate Positive	Limited	Unclear	1
Low Carbohydrate diet	Body weight	Moderate Positive	Limited	Unclear	1
Metformin	Body weight	Moderate Positive	Limited	Unclear	1
Pioglitazone	Body weight	Moderate Negative	Weak	Unclear	1
Semaglutide	BMI	Moderate Positive	Limited	Unclear	1
Semaglutide	Body weight	Moderate Positive	Limited	Consistent	2
Telemonitoring	Body weight	Neutral	Weak	Unclear	1
Telephone counseling	BMI	Moderate Positive	Limited	Unclear	1
Tirzepatide	BMI	Moderate Positive	Limited	Unclear	1

Intervention → Outcome

Basal insulin → Body weight

Effectiveness

Moderate Negative

Strength

Weak

Consistency

Unclear

Studies

Intervention → Outcome

Boscisucrophage → Body weight

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Dapagliflozin → Body weight

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Exercise therapy → Pregnancy weight gain

Effectiveness

Neutral

Strength

Weak

Consistency

Unclear

Studies

Intervention → Outcome

GLP 1 receptor agonists → Body weight

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Insulin Glargine Lixisenatide dosis → BMI

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Insulin Glargine Lixisenatide dosis → Body weight

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Liraglutide → Body weight

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Low Carbohydrate diet → BMI

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Low Carbohydrate diet → Body weight

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Metformin → Body weight

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Pioglitazone → Body weight

Effectiveness

Moderate Negative

Strength

Weak

Consistency

Unclear

Studies

Intervention → Outcome

Semaglutide → BMI

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Semaglutide → Body weight

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Consistent

Studies

Intervention → Outcome

Telemonitoring → Body weight

Effectiveness

Neutral

Strength

Weak

Consistency

Unclear

Studies

Intervention → Outcome

Telephone counseling → BMI

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies

Intervention → Outcome

Tirzepatide → BMI

Effectiveness

Moderate Positive

Strength

Limited

Consistency

Unclear

Studies